{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "regularMarketChangePercent": 4.434252, "regularMarketPrice": 61.47, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.17, "epsForward": -1.37, "epsCurrentYear": -1.5, "priceEpsCurrentYear": -40.98, "sharesOutstanding": 46225200, "bookValue": 5.797, "fiftyDayAverage": 54.0901, "fiftyDayAverageChange": 7.379902, "fiftyDayAverageChangePercent": 0.13643721, "twoHundredDayAverage": 54.659576, "twoHundredDayAverageChange": 6.810425, "twoHundredDayAverageChangePercent": 0.1245971, "marketCap": 2841463040, "forwardPE": -44.868614, "priceToBook": 10.603761, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "prevName": "Immunocore Holdings Limited", "nameChangeDate": "2023-05-14", "averageAnalystRating": "1.6 - Buy", "tradeable": false, "cryptoTradeable": false, "exchange": "NMS", "shortName": "Immunocore Holdings plc", "longName": "Immunocore Holdings plc", "messageBoardId": "finmb_133103539", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1612535400000, "priceHint": 2, "preMarketChange": 0.32999802, "preMarketChangePercent": 0.536844, "preMarketTime": 1684154407, "preMarketPrice": 61.8, "regularMarketChange": 2.6100006, "regularMarketTime": 1683921604, "regularMarketDayHigh": 61.7, "regularMarketDayRange": "59.0 - 61.7", "regularMarketDayLow": 59.0, "regularMarketVolume": 745654, "regularMarketPreviousClose": 58.86, "bid": 0.0, "ask": 65.0, "bidSize": 8, "askSize": 8, "fullExchangeName": "NasdaqGS", "financialCurrency": "GBP", "regularMarketOpen": 59.23, "averageDailyVolume3Month": 260596, "averageDailyVolume10Day": 301940, "fiftyTwoWeekLowChange": 35.35, "fiftyTwoWeekLowChangePercent": 1.353369, "fiftyTwoWeekRange": "26.12 - 69.055", "fiftyTwoWeekHighChange": -7.584999, "fiftyTwoWeekHighChangePercent": -0.10983997, "fiftyTwoWeekLow": 26.12, "fiftyTwoWeekHigh": 69.055, "earningsTimestamp": 1683698400, "earningsTimestampStart": 1683698400, "earningsTimestampEnd": 1683698400, "trailingAnnualDividendRate": 0.0, "displayName": "Immunocore", "symbol": "IMCR"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "92 Park Drive", "address2": "Milton Park", "city": "Abingdon", "zip": "OX14 4RY", "country": "United Kingdom", "phone": "44 12 3543 8600", "website": "https://www.immunocore.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also developing other programs for oncology comprise tebentafusp that is in Phase 2/3 clinical trial in patients with advanced melanoma; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising cutaneous melanoma, ovarian, non-small cell lung cancer, and endometrial; IMC-T119C for multiple solid tumor cancers; IMC-P115C for multiple solid tumor cancers; and IMC-R117C, which is for a range of tumors, including colorectal, gastro-esophageal, and pancreatic cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in Phase 1 clinical trial for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.", "fullTimeEmployees": 408, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bahija  Jallal Ph.D.", "age": 60, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 1417606, "fmt": "1.42M", "longFmt": "1,417,606"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Brian R. Di Donato M.B.A.", "age": 55, "title": "CFO & Head of Strategy", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Annelise  Vuidepot Ph.D.", "title": "CTO and Head of Pipeline & Platform Research", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Clayton  Robertson", "title": "Head of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Lily  Hepworth", "title": "Gen. Counsel & Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Amy  Judge-Prein", "title": "Chief Compliance Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. S\u00e9bastien  Desprez", "title": "Head of Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Tina St. Leger", "age": 53, "title": "Chief HR Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David  Berman M.D., Ph.D.", "age": 51, "title": "Head of R&D", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Debra  Nielsen", "title": "Chief of Staff", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}